Mike’s expertise is in global pricing and market access (P&MA) strategy development. With 15 years’ experience, Mike has led consulting engagements and advisory board meetings focused on strategic pricing, reimbursement landscape, P&MA situation analysis, identification and articulation of asset value proposition, business development due diligence assessment (for buyers as well as sellers), trial design optimization, HEOR evidence generation, and value message testing. Prior to joining Evidera, Mike managed access and opportunity assessments as director of commercial strategy and reimbursement at United BioSource Corporation, and earlier at Harris Interactive, Roger Green + Associates, and TVG. Mike began in healthcare as a children’s mental health policy researcher at the University of Rochester.
His research has been published in peer-reviewed journals such as the Journal of Neuroscience Nursing and the Journal of Ambulatory Pediatrics. He was a PhD candidate (all but dissertation) in political science at the University of Rochester, where he earned an MS in public policy analysis, an MA in political science, and a BA magna cum laude in political science.